Dr Stephanie Lynn Hightower, MD, | |
Walter Reed National Military Medical Center, 8901 Wisconsin Ave, Bethesda, MD 20889 | |
(301) 295-4191 | |
Not Available |
Full Name | Dr Stephanie Lynn Hightower |
---|---|
Gender | Female |
Speciality | Internal Medicine - Pulmonary Disease |
Location | Walter Reed National Military Medical Center, Bethesda, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689935363 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | DR.0053262 (Colorado) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | DR.0053262 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Stephanie Lynn Hightower, MD, Walter Reed National Military Medical Center, 8901 Wisconsin Ave, Bethesda, MD 20889 Ph: (301) 295-4191 | Dr Stephanie Lynn Hightower, MD, Walter Reed National Military Medical Center, 8901 Wisconsin Ave, Bethesda, MD 20889 Ph: (301) 295-4191 |
News Archive
An experimental cancer drug works differently than intended and shows significant promise for stopping melanoma and possibly other forms of cancer, research from the University of Virginia School of Medicine suggests.
According to researchers in the U.S. a mechanism found in some people's brain could be the key to them staying relaxed in stressful situations.
The U.S. Department of Health and Human Services has released details of the President's FY 2008 budget request to Congress for the department.
RegeneRx Biopharmaceuticals, Inc. announced today that the first patient has been screened and is being enrolled in a Phase 2 clinical trial testing the Company's drug candidate RGN-259 in patients with dry eye associated with graft vs. host disease. The double-blind, placebo-controlled, investigator-sponsored trial is expected to enroll a total of 20 patients over the next several months, with data reported later in 2011. RGN-259 is a sterile, preservative-free topical eye drop formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4.
When it comes to pain, the two competing schools of thought are that it's either "all in your head" or "all in your body". A new study led by University of Oxford researchers indicates that, instead, pain is an amalgam of the two.
› Verified 7 days ago
Ardalan Enkeshafi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6410 Rockledge Dr Ste 304, Bethesda, MD 20817 Phone: 443-602-6207 | |
Dr. Tara Palmore, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Center Dr, Msc 1888, Bethesda, MD 20892 Phone: 301-496-4000 | |
Dr. Cornelia Diana Cudrici, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Center Drive Bld 10 Rm 6n216a, Bethesda, MD 20892 Phone: 301-443-5519 | |
Shanthi Murgesh Nadar, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8600 Old Georgetown Road, Bethesda, MD 20814 Phone: 301-896-3100 | |
Dr. Nicole Jeanine Gormley, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 10 Center Dr, Bldg 10, Rm 2c145, Bethesda, MD 20892 Phone: 301-496-9320 | |
Dr. Harshkumar Patel, MBBS Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 10 Center Dr, Bethesda, MD 20892 Phone: 301-496-9320 Fax: 301-402-1213 | |
Dr. Tung N Dao, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6410 Rockledge Dr, Ste 200, Bethesda, MD 20817 Phone: 301-897-5301 Fax: 301-564-4289 |